Home - Products - Cell Cycle/DNA Damage - HDAC - Belinostat

Belinostat

CAS No. 414864-00-9

Belinostat ( PXD101 )

Catalog No. M14420 CAS No. 414864-00-9

Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.

Purity : >98%(HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	35	In Stock
10MG	56	In Stock
25MG	88	In Stock
50MG	132	In Stock
100MG	195	In Stock
200MG	312	In Stock
500MG	520	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Belinostat
Note

Research use only, not for human use.
Brief Description

Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.
Description

Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.
Synonyms

PXD101
Pathway

Cell Cycle/DNA Damage
Target

HDAC
Recptor

HDAC
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

414864-00-9
Formula Weight

318.35
Molecular Formula

C15H14N2O4S
Purity

>98%(HPLC)
Solubility

DMSO: 64 mg/mL (201.03 mM)
SMILES

C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO
Chemical Name

2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Savickiene J, et al. anticancer Drugs. 2014 Sep;25(8):938-49.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

HDAC8-IN-22d

HDAC8-IN-22d is a potent, selective HDAC8 inhibitor with IC50 of 27.2 nM.
BRD4354

BRD4354 is a moderately potent, selective, reversible inhibitor of HDAC5 and HDAC9 with IC50 of 0.85 uM and 1.88 uM.
SB-429201

A potent, selective HDAC1 inhibitor with IC50 of 1.5 uM.

Sign In Join Free